Antibodies, reagents, and plasmids
The antibodies used in this study include anti-p62 (Cell Signaling Technology, 5114S), anti-LC3B (Cell Signaling Technology, 3868S), anti-HA (Cell Signaling Technology, 3724S), anti-ATP6V0D1 (Proteintech,…
ATP6AP1 promotes cell proliferation and tamoxifen resistance in luminal breast cancer by inducing autophagy
